Search Results - Abu Zaid, Mohammad Issam

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Emerging Thrombotic Complications in Patients Undergoing Chimeric Antigen Receptor T Cell Therapies

    Emerging Thrombotic Complications in Patients Undergoing Chimeric Antigen Receptor T Cell Therapies by Espinoza-Gutarra, Manuel Ricardo, Schorr, Christopher, Krishnan, Maya, Abu Zaid, Mohammad Issam, Mehta, Rakesh P., Perna, Fabiana

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Single Cell Multiomic Analysis Reveals Relapsed and Refractory Multiple Myeloma Cells Associated with 1q, TP53, and PHF19 alterations That Affect Subclonal Chromatin Accessibility

    Single Cell Multiomic Analysis Reveals Relapsed and Refractory Multiple Myeloma Cells Associated with 1q, TP53, and PHF19 alterations That Affect Subclonal Chromatin Accessibility by Johnson, Travis S, Sudha, Parvathi, Liu, Enze, Chopra, Vivek S., Dos Santos, Cedric E., Nixon, Michael, Huang, Kun, Abonour, Rafat, Abu Zaid, Mohammad Issam, Walker, Brian A.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Patient Derived Xenografts Highlight Mouse-Specific Tumor Evolution Patterns and Genomic Diversity of Multiple Myeloma

    Patient Derived Xenografts Highlight Mouse-Specific Tumor Evolution Patterns and Genomic Diversity of Multiple Myeloma by Becker, Nathan, Liu, Enze, Sudha, Parvathi, Mikulasova, Aneta, Johnson, Travis S, Suvannasankha, Attaya, Abu Zaid, Mohammad Issam, Abonour, Rafat, Walker, Brian A.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Pre-Transplant M Protein Level Predicts Minimal Residual Disease Status after Autologous Stem Cell Transplantation in Multiple Myeloma

    Pre-Transplant M Protein Level Predicts Minimal Residual Disease Status after Autologous Stem Cell Transplantation in Multiple Myeloma by Meyer, Zachary S, Manaa, Mohamed, Han, Yan, Czader, Magdalena, Suvannasankha, Attaya, Abonour, Rafat, Farag, Sherif S, Stanley, Melissa, Abu Zaid, Mohammad Issam

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    The Pre-Existing T Cell Landscape Is Associated with Response to High Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma

    The Pre-Existing T Cell Landscape Is Associated with Response to High Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma by Abu Zaid, Mohammad Issam, Sudha, Parvathi, Johnson, Travis S, Chopra, Vivek S., Dos Santos, Cedric E., Nixon, Michael, Suvannasankha, Attaya, Farag, Sherif S, Lee, Kelvin P., Abonour, Rafat, Walker, Brian A.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Safety, Tolerability, and Efficacy of Axatilimab, a CSF-1R Humanized Antibody, for Chronic Graft-Versus-Host Disease after 2 or More Lines of Systemic Treatment

    Safety, Tolerability, and Efficacy of Axatilimab, a CSF-1R Humanized Antibody, for Chronic Graft-Versus-Host Disease after 2 or More Lines of Systemic Treatment by Lee, Stephanie J., Arora, Mukta, Defilipp, Zachariah, Abu Zaid, Mohammad Issam, Di Stasi, Antonio, Radojcic, Vedran, Meyers, Michael L., Qamoos, Hope, Ordentlich, Peter, Quaranto, Christine, Schmitt, Aaron, Gu, Yu, Salhotra, Amandeep, Pusic, Iskra, Kitko, Carrie Lynn

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    A Highly Robust Model for Predicting Outcome of Multiple Myeloma Patients By Inferring Patient-Specific Transcription Factor Activity

    A Highly Robust Model for Predicting Outcome of Multiple Myeloma Patients By Inferring Patient-Specific Transcription Factor Activity by Dong, Chuanpeng, Yu, Christina Y, Johnson, Travis S, Reiter, Jill L, Abu Zaid, Mohammad Issam, Abonour, Rafat, Roodman, G. David, Huang, Kun, Liu, Yunlong

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Development of a Novel Deep Transfer Learning Framework to Characterize Inter- and Intra-Tumor Heterogeneity in Myeloma Patients

    Development of a Novel Deep Transfer Learning Framework to Characterize Inter- and Intra-Tumor Heterogeneity in Myeloma Patients by Johnson, Travis S, Yu, Christina Y, Dong, Chuanpeng, Wang, Tongxin, Abu Zaid, Mohammad Issam, Abonour, Rafat, Roodman, G. David, Liu, Yunlong, Huang, Kun

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    A Clinically Validated Targeted Capture Panel to Identify Translocations, Copy Number Abnormalities, and Mutations in Multiple Myeloma

    A Clinically Validated Targeted Capture Panel to Identify Translocations, Copy Number Abnormalities, and Mutations in Multiple Myeloma by Sudha, Parvathi, Ahsan, Aarif, Khera, Akhil, Kazeroun, Mohammad H, Kausar, Tasneem, Wang, Lin, Angulo Salazar, Mirian, Fitzsimons, Evelyn, Salminen, Outi, Ashby, Timothy Cody, Blaney, Patrick, Czader, Magdalena, Vance, Gail, Williams, Jon, Abu Zaid, Mohammad Issam, Ramasamy, Karthik, Yong, Kwee, Morgan, Gareth J., van Rhee, Frits, Abonour, Rafat, Flynt, Erin, Ansari-Pour, Naser, Gooding, Sarah, Thakurta, Anjan, Walker, Brian A

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  10. 10
    Phase 1 Study of Axatilimab (SNDX-6352), a CSF-1R Humanized Antibody, for Chronic Graft-Versus-Host Disease after 2 or More Lines of Systemic Treatment

    Phase 1 Study of Axatilimab (SNDX-6352), a CSF-1R Humanized Antibody, for Chronic Graft-Versus-Host Disease after 2 or More Lines of Systemic Treatment by Arora, Mukta, Jagasia, Madan, Di Stasi, Antonio, Meyers, Michael L, Quaranto, Christine, Schmitt, Aaron, Sankoh, Serap, Abu Zaid, Mohammad Issam, Hill, Geoff R, Weisdorf, Daniel J., Blazar, Bruce R., Ordentlich, Peter, Lee, Stephanie J.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  11. 11
    Final Results of Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib in Acute Myeloid Leukemia with FLT3-ITD Mutation or Poor-Risk Cytogenetics

    Final Results of Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib in Acute Myeloid Leukemia with FLT3-ITD Mutation or Poor-Risk Cytogenetics by Saliba, Antoine N, Boswell, H. Scott, Cripe, Larry D, Abu Zaid, Mohammad Issam, Weisenbach, Jill, Sayar, Hamid

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  12. 12
    The Impact of the Implementation of Capability Maturity Model Integration on User Satisfaction: Case Study on Software Companies in Jordan

    The Impact of the Implementation of Capability Maturity Model Integration on User Satisfaction: Case Study on Software Companies in Jordan by Issam Khalil Abu-Baker, Mohammad, Khair Saleem Abu-Zaid, Mohammad, Alsawalqah, Hamad, Al-Shamayleh, Yazan, Al-Shboul, Bashar

    Published in Journal of software
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: